Bioresponsive mesoporous silica nanoparticles for triggered drug release

350Citations
Citations of this article
321Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mesoporous silica nanoparticles (MSNPs) have garnered a great deal of attention as potential carriers for therapeutic payloads. However, achieving triggered drug release from MSNPs in vivo has been challenging. Here, we describe the synthesis of stimulus-responsive polymer-coated MSNPs and the loading of therapeutics into both the core and shell domains. We characterize MSNP drug-eluting properties in vitro and demonstrate that the polymer-coated MSNPs release doxorubicin in response to proteases present at a tumor site in vivo, resulting in cellular apoptosis. These results demonstrate the utility of polymer-coated nanoparticles in specifically delivering an antitumor payload. © 2011 American Chemical Society.

Cite

CITATION STYLE

APA

Singh, N., Karambelkar, A., Gu, L., Lin, K., Miller, J. S., Chen, C. S., … Bhatia, S. N. (2011). Bioresponsive mesoporous silica nanoparticles for triggered drug release. Journal of the American Chemical Society, 133(49), 19582–19585. https://doi.org/10.1021/ja206998x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free